{"id":"W4408167066","doi":"10.1200/jco-24-01283","title":"Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôtel-Dieu de Québec; Université Laval; Lakeridge Health","funders":"","keywords":"Docetaxel; Medicine; Prostate cancer; Pembrolizumab; Oncology; Double blind; Internal medicine; Randomized controlled trial; Prostate; Urology; Chemotherapy; Cancer; Placebo; Pathology; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002063119,0.001652588,0.002094344,0.0003555522,0.0005021917,0.00123917,0.0008570595,0.001752194,0.007156183],"category_scores_gemma":[0.002087628,0.000568564,0.001284118,0.0003860349,0.0008602861,0.001050426,0.000355702,0.002980888,0.001314759],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007924757,"about_ca_system_score_gemma":0.001140089,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008303919,"about_ca_topic_score_gemma":0.00206174,"domain_scores_codex":[0.9992498,0.0004229578,0.00004002371,0.0001302653,0.00006944854,0.00008748595],"domain_scores_gemma":[0.9993669,0.0001523214,0.0001905795,0.0000462574,0.00004689068,0.0001969786],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9632143,0.00656069,0.0003399108,0.001109335,0.0008435636,0.00003668518,0.00004792956,0.0004109986,0.002256136,0.0002615711,0.002191173,0.02272766],"study_design_scores_gemma":[0.965916,0.03113211,0.000753246,0.00005891234,0.0002811845,0.00003566674,0.00001201616,0.000276344,0.0002543639,0.000172712,0.001097587,0.000009869127],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9448133,0.02342434,0.001923459,0.002436847,0.001932422,0.01263234,0.003655844,0.0003440243,0.008837449],"genre_scores_gemma":[0.9663009,0.007103415,0.002533626,0.002586163,0.0009710875,0.01129986,0.00199812,0.00004404858,0.007162738],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007156183,"threshold_uncertainty_score":0.02393985,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2509900570005083,"score_gpt":0.551990400322006,"score_spread":0.3010003433214977,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}